Amedeo Smart

Free Medical Literature Service

 

Amedeo

Vaccines
  Free Subscription

20.04.2026

3 BMJ
3 Clin Infect Dis
1 Infect Immun
1 J Immunol
1 J Virol
2 JAMA
2 Lancet
1 PLoS Comput Biol
3 PLoS One
1 Proc Natl Acad Sci U S A
23 Vaccine
3 Virology


    BMJ

  1. O'DOWD A
    Covid vaccine rollout was "extraordinary," but payouts to people harmed should rise, says UK inquiry.
    BMJ. 2026;393:s729.
    >> Share

  2. DAVIES SR, Davies AL, Higgins JPT, Caldwell DM, et al
    Effectiveness of interventions to increase vaccine uptake: component network meta-analysis.
    BMJ. 2026;393:e087578.
    >> Share

  3. SINGH M, Joshi S, Vohra V, Sarin R, et al
    Efficacy and safety of VPM1002 and Immuvac in preventing tuberculosis: phase 3 randomised clinical trial (PreVenTB trial).
    BMJ. 2026;393:e085716.
    >> Share


    Clin Infect Dis

  4. TUITE AR, Warshawsky BF, Friedman L, Kwong JC, et al
    Vaccine Performance Helps Explain Heterogeneity in Indirect Protection Across Influenza Vaccine Trials.
    Clin Infect Dis. 2026 Apr 17:ciag260. doi: 10.1093.
    >> Share

  5. LEROUX-ROELS I, Lins M, Surowitz R, Pragalos A, et al
    Immunogenicity and safety of co-administration of adjuvanted respiratory syncytial virus prefusion F protein vaccine with 20-valent pneumococcal conjugate vaccine in adults aged >/=60 years: a randomized, non-inferiority trial.
    Clin Infect Dis. 2026 Apr 13:ciag250. doi: 10.1093.
    >> Share

  6. REIMER JENSEN AM, Johansen ND, Wolff PS, Vaduganathan M, et al
    Electronic Nudges to Increase Influenza Vaccination in Immunosuppressed Adults Across the Age Spectrum: A Pooled Analysis of Two Nationwide Randomized Trials.
    Clin Infect Dis. 2026 Apr 12:ciag219. doi: 10.1093.
    >> Share


    Infect Immun

  7. LIU Z, Li C, Mahan S, Ren J, et al
    The oral vaccine intrOv is attenuated in infecting the lower airway and inducing chronic pathology.
    Infect Immun. 2026 Apr 15:e0012226. doi: 10.1128/iai.00122.
    >> Share


    J Immunol

  8. BISWAS S, Howlader DR, Dietz Z, Halder P, et al
    Effectiveness and immunogenicity of a nanoemulsion protein subunit vaccine against Pseudomonas aeruginosa: investigation in diet-induced obese mice.
    J Immunol. 2026;215:vkag052.
    >> Share


    J Virol

  9. TANG PCH, Ling Z, Lee M, King NJC, et al
    Combating respiratory diseases with mucosal vaccines.
    J Virol. 2026 Apr 15:e0014626. doi: 10.1128/jvi.00146.
    >> Share


    JAMA

  10. RUBIN R
    How mRNA Vaccines Could Help Treat Cancer.
    JAMA. 2026 Apr 10. doi: 10.1001/jama.2026.2088.
    >> Share

  11. ABBASI J
    PCSK9 Inhibitors in Diabetes, Tirzepatide's Cardiorenal Effects, Shingles Vaccine, and More From ACC.
    JAMA. 2026 Apr 10. doi: 10.1001/jama.2026.2399.
    >> Share


    Lancet

  12. JOHANSEN ND, Seco JP, Martinon-Torres F, Biering-Sorensen T, et al
    Unclear benefits of higher doses of influenza vaccine - Authors' reply.
    Lancet. 2026;407:1426.
    >> Share

  13. FLAHAULT A
    Unclear benefits of higher doses of influenza vaccine.
    Lancet. 2026;407:1425-1426.
    >> Share


    PLoS Comput Biol

  14. ANOKYE F, Li MWZ, Walker S, Hurford A, et al
    Quantifying SARS-CoV-2 Omicron variant spread and the impact of non-pharmaceutical interventions in Newfoundland and Labrador, Canada.
    PLoS Comput Biol. 2026;22:e1013562.
    >> Share


    PLoS One

  15. AZIZ AB, Ahmmed F, Haile K, Kering K, et al
    Risk factors for spontaneous abortion following hepatitis E vaccination during and shortly before pregnancy: Further analysis from a cluster-randomized trial.
    PLoS One. 2026;21:e0345974.
    >> Share

  16. MURALIDHAR K, Ngaybe MGB, Pope B, Nanjaiah S, et al
    Behavioural and Social Drivers (BeSD) of COVID-19 vaccination for children: A cross-sectional study of parental vaccine confidence and intent in Mysore, India.
    PLoS One. 2026;21:e0316877.
    >> Share

  17. BERBER E, Hanley HB, Gamez BM, Ross TM, et al
    Assessment of hemagglutinin-inhibition activity following influenza vaccination during the 2022-2023, 2023-2024, and 2024-2025 seasons.
    PLoS One. 2026;21:e0347314.
    >> Share


    Proc Natl Acad Sci U S A

  18. WELLS CR, Pandey A, Ye Y, Bawden C, et al
    The health and economic repercussions of declining MMR coverage in the United States.
    Proc Natl Acad Sci U S A. 2026;123:e2605971123.
    >> Share


    Vaccine

  19. WU JD, Meng H, Guo XL, Liu L, et al
    The immune response of the mRNA vaccine CS-2034 as a heterologous booster before and after breakthrough infection: A follow-up study.
    Vaccine. 2026;81:128575.
    >> Share

  20. MORELLI F, Augard C, Bourhy H, Bravo C, et al
    Factors influencing rabies vaccines immunogenicity during post-exposure prophylaxis: a systematic literature search and meta-analysis.
    Vaccine. 2026;81:128578.
    >> Share

  21. ANYALECHI EG, Marquez PL, Rubin MN, Johannsen SP, et al
    Safety of seasonal inactivated influenza vaccines in children 6 months-17 years of age in the Vaccine Adverse Events Reporting System (VAERS) 2018-2023: before, during, and after the COVID-19 pandemic public health emergency.
    Vaccine. 2026;81:128569.
    >> Share

  22. PITTET LF, Casalaz D, Donath S, Gardiner K, et al
    Effect of neonatal BCG vaccination on oral herpes in early childhood: A nested study within a randomised controlled trial.
    Vaccine. 2026;81:128577.
    >> Share

  23. DE AGUIAR GB, da Costa MG, Garcia JH, Jacobs GB, et al
    Effects of candidate vaccines against Zika virus infection: A systematic review of the clinical trials.
    Vaccine. 2026;81:128562.
    >> Share

  24. HSIEH SM, Choi MJ, Chen YC, Cheng SY, et al
    Cost-effectiveness of vaccination of older adults with an MF59(R)-adjuvanted quadrivalent influenza vaccine compared to standard-dose and high-dose vaccines in South Korea and Taiwan.
    Vaccine. 2026;80:128533.
    >> Share

  25. MCCALL KL, Park JH, Clark TM, Steinberg JD, et al
    Pharmacovigilance analysis of vaccination errors during pregnancy using VAERS data.
    Vaccine. 2026;81:128570.
    >> Share

  26. STIEHL E, Negrete M, Flores G, Federmeyer L, et al
    Empowering communities during the COVID-19 pandemic: insights from trusted messengers about their work addressing COVID-19 vaccine hesitancy.
    Vaccine. 2026;60 Suppl 1:128559.
    >> Share

  27. HAVERKATE MR, van de Kassteele J, van den Hof S, Sanders JG, et al
    The effect of pre-booked appointments on COVID-19 vaccine uptake among previously vaccinated older adults during the 2023 autumn campaign in the Netherlands: a regression discontinuity analysis.
    Vaccine. 2026;81:128565.
    >> Share

  28. XU MA, Pant S, DiClemente RJ
    Factors affecting human papillomavirus vaccination: A review of individual, interpersonal, and structural factors affecting vaccine uptake among adolescents.
    Vaccine. 2026;81:128563.
    >> Share

  29. GASHEMA P, Iradukunda PG, Rudacogora JC, Siddig EE, et al
    Unlocking Africa's vaccine Independence: The critical role of technology transfer and intellectual property.
    Vaccine. 2026;81:128573.
    >> Share

  30. OLSON NL, Mitchell PG, Armon C, Todd JK, et al
    Social vulnerability is associated with higher rate of emergency department visits and hospitalizations with vaccine preventable diseases among Colorado children.
    Vaccine. 2026;81:128585.
    >> Share

  31. GATWOOD J, Zhu Y, Steffens A, Gallagher S, et al
    Missed opportunities for herpes zoster vaccination among older adults in the United States.
    Vaccine. 2026;79:128450.
    >> Share

  32. MAUDONNET B, Silveira C, Cecatti JG, Costa ML, et al
    Factors associated with the use of COVID-19 vaccine during pregnancy: evidence from a multicenter Brazilian cross-sectional study.
    Vaccine. 2026 Apr 10:128549. doi: 10.1016/j.vaccine.2026.128549.
    >> Share

  33. ZOU Z, Zhang H, Wang X, Zhao K, et al
    Potential benefits of optimised varicella vaccination scenarios in a western Chinese province: a modelling study using real-world data.
    Vaccine. 2026;81:128587.
    >> Share

  34. KAPELUS DJ, Ranchod H, Olwagen CP, Koen A, et al
    Waning of measles immunity by 5 years of age following an accelerated two-dose measles vaccine schedule at 6 and 12 months in South African children: an observational cohort study.
    Vaccine. 2026;81:128580.
    >> Share

  35. BROWN NE, Pawloski LC, Winter K, Harriman K, et al
    Longitudinal assessment of asymptomatic infection of Bordetella pertussis among pertussis acellular vaccinated adolescents.
    Vaccine. 2026;81:128567.
    >> Share

  36. HIGGINS RA, Mazarakis N, Sun C, Toh ZQ, et al
    Effect of time-of-day vaccination on the antibody response to mRNA and protein COVID-19 vaccine in adults.
    Vaccine. 2026;81:128574.
    >> Share

  37. IBE I, Palommella V, Chilton B, Malloy N, et al
    Barriers to adult vaccination: Findings from a national survey of healthcare professionals.
    Vaccine. 2026;81:128542.
    >> Share

  38. SMET J, Smits K, Dirix V, Vermeulen F, et al
    Multiparametric analysis of vaccine-induced B and T cell responses for optimal evaluation of memory immune responses to Bordetella pertussis in children.
    Vaccine. 2026;81:128552.
    >> Share

  39. CERVELLERA F, Vecchio R, Muzzi A, Bruno R, et al
    Strengthening hospital-based vaccination models for high-risk subjects: from evidence to implementation.
    Vaccine. 2026;81:128572.
    >> Share

  40. HIRAKAWA T, Yamada G, Tokiya M, Furukawa T, et al
    Impact of pre-vaccination active vitamin D levels on COVID-19 mRNA vaccine-induced immunity in a Japanese cohort.
    Vaccine. 2026;81:128576.
    >> Share

  41. KARKI I, Pro G, Bhochhibhoya S, Teeter B, et al
    Social determinants of health associated with human papillomavirus vaccine uptake among teens.
    Vaccine. 2026;81:128586.
    >> Share


    Virology

  42. ULLAH SHAH A, Rafique S, Peddireddi L, Wood B, et al
    Genomic characterization of some infectious laryngotracheitis virus (ILTV) field isolates from vaccinated chicken farms reveals evidence of vaccine-related genetic drift.
    Virology. 2026;620:110900.
    >> Share

  43. WANG Z, Wongnak R, Oba M, Mizutani T, et al
    Omicron RBD expressed in E. coli outperforms mammalian-expressed S1 spike protein in generating highly neutralizing anti-SARS-CoV-2 antibodies in mice.
    Virology. 2026;619:110894.
    >> Share

  44. RAMUTH M, Sonoo J, Pyndiah N, Rughooputh S, et al
    Epidemiology of influenza A and B viruses in Mauritius over an 8-year period, 2009-2016.
    Virology. 2026;619:110892.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016